JUAN CARLOS
VALLEJO LLAMAS
Investigador hasta 2022
Institute Catalá Oncología
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institute Catalá Oncología (5)
2018
-
PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation
Annals of Hematology, Vol. 97, Núm. 11, pp. 2217-2224
2016
-
UGT2B17 minor histocompatibility mismatch and clinical outcome after HLA-identical sibling donor stem cell transplantation
Bone Marrow Transplantation, Vol. 51, Núm. 1, pp. 79-82
2014
-
Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation
Haematologica, Vol. 99, Núm. 10, pp. 1632-1637
2004
-
HLA-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host disease
Transplantation, Vol. 77, Núm. 7, pp. 1107-1110
2001
-
Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation
British Journal of Haematology, Vol. 114, Núm. 4, pp. 931-936